GRAND ROUNDS

In medicine, Grand Rounds are an essential teaching tool that allows medical professionals to present case studies, medical problems, and treatment best practices to an audience of doctors, residents, and medical students as a way to inform and improve patient care.

OCHIN Grand Rounds differ in a few key ways. First, while traditional Grand Rounds are typically closed events, the OCHIN Grand Rounds series is open to the public. Anyone interested in attending a session is welcome to register, and even ask questions of the presenter. OCHIN Grand Rounds also differ from the traditional practice in that they utilize technology to enhance accessibility and allow for remote attendance. Content is intended to be appropriate for a wide audience including researchers, patients, clinicians, students, and the general public. As such, these presentations are focused around our research priority areas and include learnings relevant to community health centers and safety net clinics. Additionally, OCHIN Grand Rounds are intended to engage the audience, and we encourage participants to take advantage of the ability to ask presenters their questions in real time

JOIN US FOR OUR NEXT EVENT

Friday, January 10 from 12:00 – 1:00 PM PT

ADDRESSING PERSISTENT DISPARITY IN CERVICAL CANCER: THE ROLE OF FQHCs

Dr. Kobetz’s Presentation: Will describe a collaborative research endeavor between Sylvester and Health Choice Network (HCN) over the past 10 years to address cervical cancer screening disparities
 

Attendees will Learn About:

  1. Disparities in cervical cancer incidence and mortality within the US.
  2. Barriers to routine screening across diverse patient populations.
  3. A participatory research endeavor between UM and Health Choice Network (HCN) to circumvent such barriers, increase screening uptake, and better meet HEDIS/UDS targets.

OCHIN Member Impact:
OCHIN members can think critically about participating in dissemination research opportunities to address gaps in cancer screening and other HEDIS/UDS requirements.

About Dr. Kobetz: Dr. Kobetz is a Professor in the Departments of Medicine, Public Health Sciences, and Obstetrics and Gynecology at the University of Miami (UM) Miller School of Medicine. Additionally, she is Associate Director of Population Science and Cancer Disparities at UM’s Sylvester Comprehensive Cancer Center (SCCC) and Chief of Population Health and Cancer Disparities for UHealth Oncology Service Line. Dr. Kobetz also serves as Program Director for the Community Engagement and Multidisciplinary Team Science Components of UM’s Clinical Translational Science Institute (CTSA) and is the University’s co-Vice Provost for Research (VPR). She earned a Master’s in Public Health from Rollins School of Public Health at Emory University (1999), and joined the University of Miami in September of 2004, after completing her Ph.D. at the University of North Carolina at Chapel Hill, Gillings School of Public Health.

CERVICAL CANCER RISK AND SCREENING AMONG TRANSMASCULINE (TM) ADULTS

Dr. Potter’s Presentation: After identifying cervical cancer screening disparities among transmasculine individuals at Fenway Health, our research team conducted a suite of studies to understand the root causes and develop solutions. This presentation will describe what we learned about barriers to cervical cancer screening and screening preferences in this population, as well as positive findings of a PCORI-funded study on the acceptability and performance of patient-centered screening via self-collection of a frontal (vaginal) swab for HPV DNA.

Attendees will Learn About:

  1. Transmasculine (TM) individuals who have a cervix are at risk for cervical cancer and need to be screened.
  2. Eligible TM individuals experience cervical cancer screening disparities because of distress triggered by traditional cervical cancer screening procedures.
  3. Self-collected frontal (vaginal) swabs for HPV DNA are highly acceptable to TM individuals and test performance is consistent with previous studies in cisgender females.

OCHIN Member Impact:
Educate members on: a) the need to screen according to body parts rather than gender identity, and b) acceptability and performance of self-collection of a frontal (vaginal) self-swab for HPV DNA as a cervical cancer screening option.

About Dr. Potter: Dr. Potter is a Professor of Medicine at Harvard Medical School (HMS), Co-Chair of The Fenway Institute, and primary care physician at Beth Israel Deaconess Medical Center. Dr. Potter has extensive clinical, medical education, research, and mentoring experience. She has designed and implemented numerous curricula for health professionals focused on LGBTQ populations, women’s health, cancer survivorship, and trauma-informed care. Currently, Dr. Potter serves nationally as a member of the Patient Centered Outcomes Research Institute’s Healthcare Delivery and Disparities Research Program Advisory Panel and Associate Editor of MedEdPORTAL’s LGBT Collection. At HMS, Dr. Potter has been a longstanding member of the Continuing Medical Education Committee and serves as the Advisory Dean and Director of the William B. Castle Society, Director of a Harvard Global Academy online course on LGBT health, Associate Director of the annual HMS CME course Primary Care Internal Medicine, and Faculty Co-Director of two HMS curricular themes focused on Sexual and Gender Minority Health Equity and Trauma-Informed Care.

MORE GRAND ROUND EVENTS